EIF2AK2 and obesity disorder: In mammalian cells, PKR activates JNK and insulin receptor substrate 1 and inhibits eIF2α in response to palmitic acid or thapsigargin, which stimulate obesity, resulting in the inhibition of insulin signaling [77].